← Back to Patent Explorer
US5354774A Expired / Lapsed US ⏱️ 0.0 years remaining

Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light

Assignee: Yale University
•
Filing: 1992-12-24
•
Granted: 1994-10-11
•
Expires: 2012-12-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for inhibiting smooth muscle cell proliferation in an injured blood vessel includes the steps of administering a photoactivatable psoralen to a patient in an amount to achieve local arterial tissue levels of psoralen suitable for light-dependent inhibition of smooth muscle cell growth, and delivering radiation in the visible wavelength range to the injured region of the blood vessel at a level sufficient for photoactivation of the psoralen. The psoralen is preferably 8-methoxypsoralen and can be delivered systemically or locally. The method of the invention can be used for preventing restenosis in a blood vessel following transluminal angioplasty. Both the psoralen and the visible light can be delivered with a laser balloon catheter having a porous balloon. The method of the invention may also be used for inhibiting proliferation of other undesired cell types in a patient's body.

Inventors

  • 👤 Lawrence I. Deckelbaum
  • 👤 Francis P. Gasparro
  • 👤 Bauer K. Sumpio

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/365; A61K31/366; A61K31/37; A61K41/00; A61K41/0057; A61K41/0066

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 93 words
A method for preventing restenosis in a blood vessel following transluminal angioplasty by inhibiting smooth muscle cell growth, comprising the steps of: administering a photoactivatable psoralen to a patient in need thereof, said psoralen being administered in an amount to achieve local arterial tissue levels of psoralen sufficient for inhibition of smooth muscle cell growth when the psoralen is photoactivated; and delivering radiation in the visible wavelength range equal to or greater than about 420 nanometers to the stenosed region of the blood vessel at a level sufficient for photoactivation of the psoralen.
Claim 2
Independent Claim 93 words
A method for preventing restenosis in a blood vessel following transluminal angioplasty by inhibiting smooth muscle cell growth, comprising the steps of: administering a photoactivatable psoralen to a patient in need thereof, said psoralen being administered in an amount to achieve local arterial tissue levels of psoralen sufficient for inhibition of smooth muscle cell growth when the psoralen is photoactivated; and delivering radiation in the visible wavelength range equal to or greater than about 420 nanometers to the stenosed region of the blood vessel at a level sufficient for photoactivation of the psoralen.
Claim 3
Dependent Claim 13 words
A method as defined in claim 1 wherein the psoralen is administered systemically.
Claim 4
Dependent Claim 13 words
A method as defined in claim 1 wherein the psoralen is administered locally.
Claim 5
Dependent Claim 20 words
A method as defined in claim 1 wherein the radiation is delivered to the stenosed region through an optical fiber.
Claim 6
Dependent Claim 12 words
A method as defined in claim 1 wherein the psoralen comprises 8-methoxypsoralen.
Claim 7
Dependent Claim 53 words
A method as defined in claim 1 wherein the step of administering a photoactivatable psoralen includes the steps of advancing a catheter having a porous balloon at or near its distal end to the stenosed region of the blood vessel and delivering the photoactivatable psoralen through said porous balloon to the stenosed region.
Claim 8
Dependent Claim 57 words
A method as defined in claim 6 wherein the step of delivering radiation includes providing said catheter with an optical fiber having a diffusing tip that is located within said porous balloon and delivering radiation through said optical fiber and said diffusing tip such that said radiation passes through said porous balloon and irradiates said blood vessel.
Claim 9
Independent Claim 100 words
A method for preventing restenosis in a blood vessel following transluminal angioplasty by inhibiting smooth muscle cell growth, comprising the steps of: administering a photoactivatable psoralen comprising 8-methoxypsoralen to a patient in need thereof, said psoralen being administered in an amount to achieve local arterial tissue levels of psoralen sufficient for inhibition of smooth muscle cell growth when the psoralen is activated; and delivering radiation in the visible wavelength range to the stenosed region of the blood vessel at a level sufficient for activation of the psoralen, said radiation having a maximum intensity at a wavelength of about 420 nanometers.
Claim 10
Independent Claim 100 words
A method for preventing restenosis in a blood vessel following transluminal angioplasty by inhibiting smooth muscle cell growth, comprising the steps of: administering a photoactivatable psoralen comprising 8-methoxypsoralen to a patient in need thereof, said psoralen being administered in an amount to achieve local arterial tissue levels of psoralen sufficient for inhibition of smooth muscle cell growth when the psoralen is activated; and delivering radiation in the visible wavelength range to the stenosed region of the blood vessel at a level sufficient for activation of the psoralen, said radiation having a maximum intensity at a wavelength of about 420 nanometers.

References Cited (Backward Citations)

US4684521A Cited
US4824436A Cited
US4838852A Cited
US4878492A Cited
US5114721A Cited
US5032679A Cited
US5042980A Cited
US5147289A Cited
US5116864A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-10-10 1998-04-11 1998-10-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-10-10 2002-04-11 2002-10-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-10-10 2006-04-11 2006-10-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag